NordivVMS

GI Effects Comprehensive Profile (GIFX)

Stool

21 ±5 days Days

Indications

Digestive discomfort: Bloating, cramping, abdominal pain or general digestive unease.
Gut condition concerns: Conditions such as IBS, suspected dysbiosis or functional gut disturbance where detailed stool analysis is helpful.
Irregular bowel habits: Constipation, loose stools, urgency or fluctuating stool patterns.
Signs of malabsorption: Undigested food in stool, oily stools or unexplained changes in stool appearance.
Gas and bloating: Excessive gas, distension or discomfort after meals.
Food-related symptoms: Nausea, fullness, or discomfort after certain foods.
Inflammation-type symptoms: Abdominal tenderness, general gut sensitivity or recurring digestive flare-ups.
Low energy or fatigue: Tiredness potentially linked with digestive imbalance.
Skin concerns: Rashes, irritation or breakouts that may appear alongside digestive symptoms.
Mood or cognitive changes: Brain fog, irritability or low mood that may coincide with digestive disturbances.
Post-antibiotic changes: Altered stool patterns or discomfort following recent antibiotic use.
General gut imbalance: Ongoing, unexplained symptoms affecting digestion, comfort or stool regularity.

Overview

The GI Effects Comprehensive Profile offers detailed insights into various aspects of gastrointestinal function by analysing a broad range of stool biomarkers. This assessment covers digestion and absorption markers alongside indicators related to microbiome composition, balance among beneficial microorganisms, microbial metabolites, and the presence of parasitic elements. It also incorporates composite scores reflecting functional patterns associated with digestion efficiency, microbial balance, iimmune trends, metabolic activity, and potential infection-related factors, enhanced by molecular analysis techniques targeting important bacterial groups.

This profile can provide valuable information for individuals interested in understanding factors that may influence digestive comfort and overall gut wellbeing. By examining elements such as enzyme activity, short-chain fatty acid levels, beta-glucuronidase, immune protein markers, microbial diversity, and the presence of yeast or parasitic organisms, it offers a broad perspective on gastrointestinal interactions. Additional measurements of microbial community stability and fermentation-related patterns contribute further context to digestive processes and gut environment dynamics.

Combining culture methods, molecular techniques, microscopy, and biochemical assays, the GI Effects Comprehensive Profile delivers a comprehensive overview of gut environment and function. This extensive data supports exploration of digestive capacity, microbial ecosystem balance, immune system responses and overall gut performance, making it a useful tool for those seeking to enhance their understanding of digestive health factors related to comfort, regularity, and metabolic wellbeing.

GI Effects Comprehensive Profile is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. GI Effects Comprehensive Profile is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.